AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...
Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...
FRANKLIN LAKES, N.J. and AUSTIN, Texas, Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a ...
The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...
Becton, Dickinson and Company BDX, popularly known as BD, and Babson Diagnostics announced an expansion of fingertip blood collection and testing technologies for use by U.S. health systems and other ...
Lancaster Guardian on MSN
Morecambe Bay hospitals trust pioneers painless new blood test which transforms lives of patients with learning disabilities and needle phobia
Patients with learning disabilities and needle phobia are benefiting from a painless new form of blood sampling pioneered by University Hospitals of Morecambe Bay NHS Foundation Trust.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果